b 725 (Fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release 60 mg / 120 mg)

Pill imprint b 725 has been identified as Fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release 60 mg / 120 mg.

Fexofenadine/pseudoephedrine is used in the treatment of allergic rhinitis and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Fexofenadine/pseudoephedrine 60 mg / 120 mg is not a controlled substance under the Controlled Substance Act (CSA).

Fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release

Imprint:

b 725

Strength:

60 mg / 120 mg

Color:

Peach & White

Shape:

Capsule-shape

Availability:

Rx and/or OTC

Drug Class:

Upper respiratory combinations

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Barr Laboratories Inc.

National Drug Code (NDC):

00555-0725

Inactive Ingredients:

calcium stearate
silicon dioxide
crospovidone
FD&C Yellow No. 6
aluminum oxide
D&C Yellow No. 10
hydrogenated castor oil
hypromelloses
maltodextrin
polyethylene glycol
povidone
cellulose powdered
stearic acid

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.